EyePoint Pharmaceuticals, Inc. (EYPT) Financials

EYPT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 228.2 million 61.8 million
March 31, 2026 288.2 million 57.7 million
Dec. 31, 2025 364.0 million 57.9 million
Sept. 30, 2025 251.7 million 51.5 million

EYPT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -145.1 million 22.0 million
March 31, 2026 -81.5 million 11.6 million
Dec. 31, 2025 -66.0 million 6.7 million
Sept. 30, 2025 -60.2 million 6.4 million

EYPT Net Income

No data available :(

EYPT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 180.5 million - 22.4 million
March 31, 2026 222.5 million - 20.2 million
Dec. 31, 2025 306.1 million - 22.8 million
Sept. 30, 2025 204.0 million - 21.3 million

EYPT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 86.5 million
March 31, 2026 86.0 million
Dec. 31, 2025 83.0 million
Sept. 30, 2025 70.2 million

EYPT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 2.2 million 83.6 million 14.3 million 31000
March 31, 2026 997000 72.1 million 15.2 million 3000
Dec. 31, 2025 986000 59.2 million 11.4 million -6000
Sept. 30, 2025 798000 47.8 million 14.5 million 26000

EYPT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 507000 -
March 31, 2026 696000 528000
Dec. 31, 2025 620000 375000
Sept. 30, 2025 966000 721000

EYPT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

EYPT

Price: $14.75

52 week price:
9.65
19.11

Earnings Per Share: -3.75 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 166382

Market Capitalization: 1.1 billion

Links: